Date    : 10^th December 2014

Venue : Education Centre, The Christie NHS Foundation Trust, Manchester

Course Description:

Delivered by Elaine Vickers PhD, an expert speaker on targeted cancer therapies and Director of Science Communication Ltd. This two day intermediate-level course gives research nurses and other trials staff the knowledge and confidence to discuss even the latest and most advanced targeted cancer treatments with their patients and colleagues. The course focuses on targeted treatments for solid tumours, but the information on day 1 is relevant to all cancer types. Throughout the two days, delegates are given the opportunity to digest and practice their new knowledge through a variety of practical exercises, question sheets and quizzes.

Topics Covered:

Day 1

• Molecular basis of cancer.
• The molecular processes that drive cancer growth, spread and metastasis.
• Mechanisms of drug resistance.
• The cellular makeup of cancer tissues & the role of the tumour microenvironment.

Day 2

• The current state of play of targeted cancer treatments.
• Newer approaches to targeted treatments.
• The evolution of clinical trial design.
• Targeted over-active growth pathways - monoclonal antibodies and kinase antibodies.

Target Audience:

This course is suitable for anyone with a reasonable grounding in biology or who has previously attended an “introduction to cancer” course. It presumes a level of familiarity with concepts such as DNA, genes, proteins and the cell cycle, but a refresher is provided. It is suitable for oncology nurses and anyone involved in the delivery of clinical trials.

Course Fee:

Delegate Fee: £200.00
Early Bird (before 10th October 2014): £150.00